AzTrials
AzTrials

Healthy ParticipantsNCT07172230

The Effective of Immersive Virtual Reality Distraction on Memory: Study 1

A study testing Immersive Virtual Reality in people with Healthy Participants, run by University of Washington at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The effect of virtual reality on memory. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Healthy Participants
What is being tested?
Immersive Virtual Reality
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteUnited States
Study dates
31 May 2024to 6 Nov 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Currently enrolled in a course at the University of Washington Psychology Dept., participating in the University of Washington (UW) Psychology subject pool
  • Able to read, write and comprehend English
  • Able to complete study measures
  • Willing to follow our UW approved instructions
  • 18 years of age or older
  • Exclusion Criteria: People who have already previously participated in this same study (e.g., last quarter) are not eligible to participate again.
Show all 19Show fewer
  • Not enrolled in a course at the University of Washington Psychology Dept., not participating in the UW Psychology subject pool
  • Not be able to read, write and comprehend English
  • Younger than 18 years of age.
  • Not capable of completing measures
  • Not capable of indicating pain intensity,
  • Not capable of filling out study measures,
  • Extreme susceptibility to motion sickness,
  • Seizure history,
  • Unusual sensitivity or lack of sensitivity to pain,
  • Sensitive skin,
  • Sensitive feet
  • Migraines
  • Diabetes

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Washington

    Seattle, Washington, 98195

Other trials in United States

About this study

Official title: Immersive Virtual Reality Induces Procedural Analgesia, Anxiolysis and Anterograde Amnesia: A Randomized Controlled Study 1

The effect of virtual reality on memory.

Read the detailed description

A within-subject randomized study will be conducted in healthy adults. In Study 1 (n=16), participants will complete immediate free recall after hearing a 15-word list during No VR versus during immersive VR.

Being tested
Immersive Virtual Reality, No distraction Control condition
Keywords
Virtual reality amnesia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Immersive Virtual RealityBehavioural

    Immersive VR

  • No distraction Control conditionBehavioural

    No VR during word list study phase

Study groups in NCT07172230
Study groupRoleWhat they receive
Immersive virtual realityExperimentalVR
Receives: Behavioral: Immersive Virtual Reality
No VROtherNo distraction during word list
Receives: Behavioral: No distraction Control condition

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Word Recall

    Free immediate recall of each word study list, after each list

    Measured: begin 15 seconds after the last word

  2. Distraction

    Participants subjective ratings of how distracted they were in each condition

    Measured: Measured immediately after the free recall of word list 2

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Sep 2025
  2. Study start31 May 2024
  3. Primary completion6 Nov 2024
  4. Study completion6 Nov 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
One within-subject randomized studies will be conducted in healthy adults. In Study 1 (n=16), participants will complete immediate free recall after hearing a 15-word list during No VR versus during immersive VR.
Masking
Single blind
Who is masked
Participant
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07172230
Sponsor's protocol ID
VRAnalgesia2025a
Status last verified
Sep 2025
First submitted
3 Sep 2025
Last updated
15 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: summarized aggregated data will be made available upon reasonable request

Publications

  • Hoffman HG, Fontenot MR, Garcia-Palacios A, Greenleaf WJ, Alhalabi W, Curatolo M, Flor H. Adding tactile feedback increases avatar ownership and makes virtual reality more effective at reducing pain in a randomized crossover study. Sci Rep. 2023 May 22;13(1):7915. doi: 10.1038/s41598-023-31038-4.

    PubMed 37217536

Questions about this trial

What is this clinical trial studying?

A study testing Immersive Virtual Reality in people with Healthy Participants, run by University of Washington at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 19 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Word Recall (time frame: begin 15 seconds after the last word). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07172230, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in